BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25436889)

  • 1. Nifedipine promotes the proliferation and migration of breast cancer cells.
    Guo DQ; Zhang H; Tan SJ; Gu YC
    PLoS One; 2014; 9(12):e113649. PubMed ID: 25436889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
    Chovancova B; Liskova V; Miklikova S; Hudecova S; Babula P; Penesova A; Sevcikova A; Durinikova E; Novakova M; Matuskova M; Krizanova O
    Biochem Pharmacol; 2020 Jan; 171():113695. PubMed ID: 31706846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine stimulates proliferation and migration of different breast cancer cells by distinct pathways.
    Zhao T; Guo D; Gu Y; Ling Y
    Mol Med Rep; 2017 Aug; 16(2):2259-2263. PubMed ID: 28656309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.
    Gao G; Liang X; Ma W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3839-3846. PubMed ID: 31556312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.
    Ryu S; McDonnell K; Choi H; Gao D; Hahn M; Joshi N; Park SM; Catena R; Do Y; Brazin J; Vahdat LT; Silver RB; Mittal V
    Cancer Cell; 2013 Jan; 23(1):63-76. PubMed ID: 23328481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
    Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
    Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
    Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
    Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration.
    Xiong J; Wei B; Ye Q; Liu W
    Biochem Biophys Res Commun; 2019 Aug; 516(3):1013-1018. PubMed ID: 27003255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
    Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
    Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
    Ho JY; Hsu RJ; Liu JM; Chen SC; Liao GS; Gao HW; Yu CP
    Oncotarget; 2017 Apr; 8(14):22443-22459. PubMed ID: 27705918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.